Authors: Martinsson, P Liminga, G Dhar, S de la Torre, M Lukinius, A Jonsson, E Hassan, SB Binderup, L Kristensen, J Larsson, R

Citation: P. Martinsson et al., Temporal effects of the novel antitumour pyridyl cyanoguanidine (CHS 828) on human lymphoma cells, EUR J CANC, 37(2), 2001, pp. 260-267

Authors: Hassan, SB de la Torre, M Nygren, P Karlsson, MO Larsson, R Jonsson, E

Citation: Sb. Hassan et al., A hollow fiber model for in vitro studies of cytotoxic compounds: activityof the cyanoguanidine CHS 828, ANTI-CANC D, 12(1), 2001, pp. 33-42

Authors: Jonsson, E Friberg, LE Karlsson, MO Hassan, SB Nygren, P Kristensen, J Tholander, B Binderup, L Larsson, R

Citation: E. Jonsson et al., In vivo activity of CHS 828 on hollow-fibre cultures of primary human tumour cells from patients, CANCER LETT, 162(2), 2001, pp. 193-200

Authors: Hassan, SB Jonsson, E Larsson, R Karlsson, MO

Citation: Sb. Hassan et al., Model for time dependency of cytotoxic effect of CHS 828 in vitro suggeststwo different mechanisms of action, J PHARM EXP, 299(3), 2001, pp. 1140-1147

Authors: Jonsson, E Friberg, LE Karlsson, MO Hassan, SB Freijs, A Hansen, K Larsson, R

Citation: E. Jonsson et al., Determination of drug effect on tumour cells, host animal toxicity and drug pharmacokinetics in a hollow-fibre model in rats, CANC CHEMOT, 46(6), 2000, pp. 493-500